Similarly, alpha1 and alpha2 sources in occipital, temporal and limbic areas as examined by LORETA was demonstrated to have lower amplitude in AD and MCI patients with ApoE ε4 genotype compared with those non-carrying ApoE ε4 (Babiloni et al., 2006b). Here, APOE is linked to Alzheimer disease.